These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11125784)

  • 1. Substance abuse prevention: moving from science to policy.
    Morin SF; Collins C
    Addict Behav; 2000; 25(6):975-83. PubMed ID: 11125784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An expensive policy: the impact of inadequate funding for substance abuse treatment.
    Amaro H
    Am J Public Health; 1999 May; 89(5):657-9. PubMed ID: 10224973
    [No Abstract]   [Full Text] [Related]  

  • 3. Research, public policy and drug abuse: current approaches and new directions.
    Smith JP
    Int J Addict; 1990-1991; 25(2A):181-97; discussion 198-9. PubMed ID: 2176648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Government prevention policy and the relevance of social cost estimates.
    Wagstaff A
    Br J Addict; 1987 May; 82(5):461-7. PubMed ID: 3474003
    [No Abstract]   [Full Text] [Related]  

  • 5. Spending on substance abuse treatment: how much is enough?
    Meara E; Frank RG
    Addiction; 2005 Sep; 100(9):1240-8. PubMed ID: 16128713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication for research of the 1988 Anti-Drug Abuse Act.
    Schuster CR
    NIDA Res Monogr; 1989; 95():16-22. PubMed ID: 2640964
    [No Abstract]   [Full Text] [Related]  

  • 7. Reducing the harms of drug policy: an economic perspective.
    Rasmussen DW; Benson BL
    Subst Use Misuse; 1999 Jan; 34(1):49-67. PubMed ID: 10052390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug abuse in the United States. Strategies for prevention.
    JAMA; 1991 Apr; 265(16):2102-7. PubMed ID: 1901609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Australian governments' spending on preventing and responding to drug abuse should target the main sources of drug-related harm and the most cost-effective interventions.
    McDonald D
    Drug Alcohol Rev; 2011 Jan; 30(1):96-100. PubMed ID: 21219503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Directions for future research in drug abuse prevention.
    Pentz MA
    Prev Med; 1994 Sep; 23(5):646-52. PubMed ID: 7845932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International illicit drug traffic: the United States response.
    Williamson RS
    Bull Narc; 1983; 35(4):33-45. PubMed ID: 6563924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choosing between competing health priorities. A government payer perspective.
    Leese J
    Pharmacoeconomics; 1996; 9 Suppl 3():4-7; discussion 23-5. PubMed ID: 10160486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of drug prevention system development in Romania and its impact on youth drug consumption trends, 1995-2005.
    Dégi CL
    Drug Alcohol Rev; 2009 Jul; 28(4):419-25. PubMed ID: 19594796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is public about public health?
    Beauchamp DE
    Health Aff (Millwood); 1983; 2(4):76-87. PubMed ID: 6674096
    [No Abstract]   [Full Text] [Related]  

  • 15. Does treatment 'pay for itself'? Looking at the economic argument for addiction treatment.
    Ettner SL
    Behav Healthc; 2006 May; 26(5):32-4. PubMed ID: 16736917
    [No Abstract]   [Full Text] [Related]  

  • 16. Disseminating science-based prevention: lessons learned from CSAP's CAPTs.
    Hogan JA; Baca I; Daley C; Garcia T; Jaker J; Lowther M; Klitzner M
    J Drug Educ; 2003; 33(3):233-43. PubMed ID: 15022858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Science, policy and practice--lessons from America.
    Hansen WB; Dusenbury L
    Adicciones; 2007; 19(2):117-24. PubMed ID: 17691413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research, policy, and the federal role in prevention initiatives for children.
    Ripple CH; Zigler E
    Am Psychol; 2003; 58(6-7):482-90. PubMed ID: 12971195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compulsory substance-user treatment and harm reduction: a critical analysis.
    Wild TC
    Subst Use Misuse; 1999 Jan; 34(1):83-102. PubMed ID: 10052392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing state substance abuse prevention infrastructure through the lens of CSAP's Strategic Prevention Framework.
    Piper D; Stein-Seroussi A; Flewelling R; Orwin RG; Buchanan R
    Eval Program Plann; 2012 Feb; 35(1):66-77. PubMed ID: 22054526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.